|
WO2021026130A1
|
|
Compositions and methods of treating psoriasis and atopic dermatitis using prevotella histicola
|
|
WO2021025968A1
|
|
Methods and compositions for culturing hemoglobin-dependent bacteria
|
|
WO2021022110A1
|
|
Inducing immune effects using bacteria of the genus bifidobacterium
|
|
WO2020257390A1
|
|
Compositions and methods of treating a th2-mediated condition using prevotella
|
|
WO2020252144A1
|
|
Secreted microbial extracellular vesicles
|
|
WO2020237009A1
|
|
Methods and compositions for anaerobic bacterial fermentation
|
|
WO2020172492A2
|
|
Bacterial membrane preparations
|
|
WO2020006216A1
|
|
Compositions and methods of treating cancer using neisseria bacteria
|
|
WO2019178494A1
|
|
Compositions and methods for treating cancer and inflammation using tyzzerella nexilis
|
|
WO2019178487A2
|
|
Compositions and methods for treating disease using klebsiella quasipneumoniae subsp. similipneumoniae
|
|
WO2019178490A1
|
|
Compositions and methods for treating cancer and inflammation using klebsiella oxytoca
|
|
WO2019178057A1
|
|
Methods of treating cancer using burkholderia
|
|
WO2019178055A1
|
|
Extracellular vesicles from burkholderia
|
|
WO2019169160A1
|
|
Compositions and methods for treating cancer using ruminococcus gnavus
|
|
WO2019169168A1
|
|
Compositions and methods for treating cancer using agathobaculum
|
|
WO2019169143A1
|
|
Compositions and methods for treating cancer using turicibacter sanguinis
|
|
WO2019169181A1
|
|
Compositions and methods for treating cancer using lactobacillus salivarius
|
|
WO2019169138A1
|
|
Compositions and methods for treating cancer using paraclostridium benzoelyticum
|
|
AU2019217526A1
|
|
Compositions and methods for treating cancer and immune disorders using Veillonella bacteria
|
|
CN111712260A
|
|
Compositions and methods for treating immune disorders using bacteria of the family lachnospiraceae
|
